SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Asymptomatic Covid-19 infection could be higher than thought
Thurs May 28th - The number of people with Covid-19 who are asymptomatic could be much higher than previously thought, according to an analysis of a cruise ship outbreak published today. More
DCIS doubles future breast cancer risk
Thurs May 28th - Women diagnosed with ductal carcinoma in situ during breast screening face an increased risk of developing breast cancer later in life, a study published today says. More
RECENT COMMENTS
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...
OTHER NEWS FEEDS OF INTEREST
ENGLEMED HEALTH NEWS

Chondroitin sulfate "effective" knee treatment

Wednesday May 24th, 2017

Treatment of knee osteoarthritis with chondroitin sulfate is equally effective as non-steroidal anti-inflammatory drugs, researchers say today.

Professor Jean-Yves Reginster, of Liege State University, Belgium, say chondroitin sulfate, often sold as a dietary supplement, should be considered a first-line treatment for the condition.

The researchers carried out a six month clinical trial of 604 patients comparing placebo, celecoxib (200mg/day), and pharmaceutical grade chondroitin sulfate (800mg/day).

They report in Annals of the Rheumatic Diseases today (24 May) that: "Chondroitin sulfate and celecoxib showed a greater significant reduction in pain than placebo. No difference was observed between chondroitin sulfate and celecoxib."

They add: "All treatments demonstrated excellent safety profiles. This formulation of chondroitin sulfate should be considered a first-line treatment in the medical management of knee osteoarthritis."

Separate findings published in the same journal suggest that a higher fibre intake is linked with less severe symptoms of knee osteoarthritis.

The findings are based on two long-term studies based in the US, one with 5,000 men and women with an average age of 61, and the other which follows the health of more than 1,200 adult children of the original Framingham Heart Study and their partners since 1971.

After four years, eating more fibre was linked to a lower risk of symptomatic knee osteoarthritis, say the researchers. Those with the highest intake had a 30% lower risk in the first study, and a 61% lower risk in the second.

"These data demonstrate a consistent protective association between total fibre intake and symptom-related knee osteoarthritis in two study populations," the authors conclude.

Reginster, J-Y, et al. Pharmaceutical-grade chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT). Annals of the Rheumatic Diseases 23 May 2017 doi 10.1136/annrheumdis-2016-210860 [abstract]

Dai, Z. et al. Dietary intake of fibre and risk of knee osteoarthritis in two US prospective cohorts. Annals of the Rheumatic Diseases 23 May 2017; doi 10.1136/annrheumdis-2016-210810 [abstract]

Tags: Diet & Food | Europe | Pharmaceuticals | Rheumatology

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES